75%Confidence
0Views
FDASource
2026-03-22Date
Summary
Kirkman's recall of Vasocaine Spray due to unsupported expiry dates indicates potential stability testing deficiencies that could affect product efficacy. This raises concerns about the company's quality management systems and may trigger broader review of their topical anesthetic product line.
Actionable: Verify expiry date validation for all topical anesthetic products and consider additional stability testing for critical items.
AI Confidence: 75%
Data Points
firmHTO Nevada Inc. dba Kirkman
classificationClass II
statusOngoing
distributionNationwide within the U.S
productFIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-01
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now